Curebound Names Robin Toft as Chief Executive Officer
Founding CEO Anne Marbarger to join board of directors and serve as advisor SAN DIEGO–(BUSINESS WIRE)–#ExecutiveSearch—Curebound, a philanthropic... Read more.
Law Offices of Frank R. Cruz Encourages Alexandria Real Estate Equities, Inc. (ARE) Shareholders To Inquire About Securities Fraud Class Action
LOS ANGELES–(BUSINESS WIRE)–The Law Offices of Frank R. Cruz announces that a class action lawsuit has been filed on behalf of shareholders who purchased... Read more.
Fastco, a Subsidiary of Groupe Touchette, Announces the Acquisition of ENVY Wheel Brand
VAUDREUIL-DORION, Quebec–(BUSINESS WIRE)–Fastco Canada, a proudly Canadian-owned leader in aftermarket alloy wheels, announces the acquisition of the... Read more.
Payman AI Partners with Middlesex Federal Savings to Launch their Agentic Banking Experience
DURANGO, Colo.–(BUSINESS WIRE)–Payman AI, the infrastructure platform enabling secure AI agents in community banking, announced a partnership with Middlesex... Read more.
WRITER and AWS Team Up to Make Enterprise Agents More Scalable and Secure
WRITER announces new agent supervision suite and native integration with Amazon Bedrock to bring model flexibility and enhanced agent security to its platform SAN... Read more.
Korn Ferry to Report Quarterly Earnings via Live Webcast on December 9, 2025
LOS ANGELES–(BUSINESS WIRE)–Korn Ferry (NYSE:KFY) today announced that the firm will release financial results for the second quarter of fiscal year... Read more.
TD SYNNEX Awarded 2025 AWS Partner Awards
TD SYNNEX recognized as North American and Latin American Distributor Partner of the Year, one of many AWS Partners around the globe that help their customers drive... Read more.
Compounding Pharmacy Market Trends and Strategy Outlook to 2030 – The Pain Management Segment Dominates Pharmaceutical Applications with Targeted Therapies – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Compounding Pharmacy Market by Product (Oral, Topical, Parenteral), Compounding Type (Ingredient Alteration, Dosage... Read more.
GenSight Biologics Announces Regulatory Approval for GS010/LUMEVOQ® REVISE Dose-Ranging Study in France
French medicines agency ANSM and Ethics Committee authorize the dose-ranging study investigating two doses of candidate product for the treatment of ND4-LHON. Approval... Read more.
Trends & Strategies Shaping the $2.22 Billion Smart Syringes Market, 2025-2033 – Government-Led Immunization Initiatives Propel Uptake of Auto-Disable Smart Syringes – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Smart Syringes Market Forecast to 2033” has been added to ResearchAndMarkets.com’s offering. The global... Read more.